In accordance with this, we also observed changed NR4A2 expression in gastric adenocarcinomas, seemingly being dominated by a general expression in tumor cells compared to the mainly strong NR4A2 expression in the gastrin responsive neuroendocrine ECL cells in normal mucosa. The gene discussed is GAST; the disease is gastric adenocarcinoma.